1. Home
  2. LEGN vs SBSW Comparison

LEGN vs SBSW Comparison

Compare LEGN & SBSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • SBSW
  • Stock Information
  • Founded
  • LEGN 2014
  • SBSW 2013
  • Country
  • LEGN United States
  • SBSW South Africa
  • Employees
  • LEGN N/A
  • SBSW N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • SBSW Precious Metals
  • Sector
  • LEGN Health Care
  • SBSW Basic Materials
  • Exchange
  • LEGN Nasdaq
  • SBSW Nasdaq
  • Market Cap
  • LEGN 5.4B
  • SBSW 5.3B
  • IPO Year
  • LEGN 2020
  • SBSW N/A
  • Fundamental
  • Price
  • LEGN $38.96
  • SBSW $8.27
  • Analyst Decision
  • LEGN Strong Buy
  • SBSW Hold
  • Analyst Count
  • LEGN 12
  • SBSW 3
  • Target Price
  • LEGN $73.91
  • SBSW $4.73
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • SBSW 9.5M
  • Earning Date
  • LEGN 08-08-2025
  • SBSW 07-22-2025
  • Dividend Yield
  • LEGN N/A
  • SBSW N/A
  • EPS Growth
  • LEGN N/A
  • SBSW N/A
  • EPS
  • LEGN N/A
  • SBSW N/A
  • Revenue
  • LEGN $728,303,000.00
  • SBSW $5,938,469,800.00
  • Revenue This Year
  • LEGN $65.49
  • SBSW $8.03
  • Revenue Next Year
  • LEGN $53.76
  • SBSW $2.88
  • P/E Ratio
  • LEGN N/A
  • SBSW N/A
  • Revenue Growth
  • LEGN 112.46
  • SBSW N/A
  • 52 Week Low
  • LEGN $27.34
  • SBSW $3.05
  • 52 Week High
  • LEGN $60.87
  • SBSW $8.29
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 66.26
  • SBSW 68.85
  • Support Level
  • LEGN $34.64
  • SBSW $7.41
  • Resistance Level
  • LEGN $39.88
  • SBSW $8.07
  • Average True Range (ATR)
  • LEGN 1.46
  • SBSW 0.24
  • MACD
  • LEGN 0.37
  • SBSW 0.02
  • Stochastic Oscillator
  • LEGN 87.67
  • SBSW 97.96

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About SBSW D/B/A Sibanye-Stillwater Limited ADS

Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other.

Share on Social Networks: